secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001493152-26-004733
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma issues 21.4M shares in Jan 2026 for $69,550, massive dilution
-----------------------------------------------------------------------------

- On Jan 15, 2026, issued 5,000,000 shares to satisfy $11,449 principal + $8,101 interest on convertible debt.
- On Jan 29, 2026, issued 5,302,732 shares to satisfy $12,000 principal + $1,000 interest.
- On Jan 30, 2026, issued 11,111,111 shares for $50,000 cash via Reg A offering.
- As of Feb 2, 2026, total shares outstanding: 129,468,577; implied average issuance price ~$0.003 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000149315226004733/0001493152-26-004733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000149315226004733/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer